Novo Nordisk A/S (NVO) News

Novo Nordisk A/S (NVO)

Today's Latest Price: $63.89 USD

2.44 (-3.68%)

Updated Oct 30 7:00pm

Add NVO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Filter NVO News Items

NVO News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest NVO News From Around the Web

Below are the latest news stories about Novo Nordisk A S that investors may wish to consider to help them evaluate NVO as an investment opportunity.

Revisiting Novo Nordisk

I regularly covered Novo Nordisk (NVO) in the past and will provide another update in the following article. After looking at the last quarterly results (or to be more precise: the results of the first half of 2020), I will look at the problems the company has been facing in...

Daniel Schönberger on Seeking Alpha | October 2, 2020

Insulin API Market Prescribes Strong Growth, Business Enhancing Strategies, CAGR Status, by Forecast 2025| Sanofi, Novo Nordisk

The research study covers the current scenario and growth prospects of the Insulin API market (2020-2025) according to the analysis . This study includes a extensive analysis of the key segments of the industry and also the regional analysis

OpenPR | October 2, 2020

Global $6 Billion Diabetes Reusable Insulin Delivery Pen Market to 2026 with Sanofi, Ypsomed, Biocon, Novo Nordisk, Eli Lilly and Co, Owen Mumford & Berlin-Chemie Dominating

DUBLIN , Oct. 2, 2020 /PRNewswire/ -- The "Worldwide Diabetes Reusable Insulin Delivery Pen Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The Worldwide Diabetes Reusable Insulin Delivery Pen Market size is expected to touch US$ 6 billion by 2026. The report offers the most up-to-date industry data on the actual market situation and future outlook for the worldwide diabetes reusable insulin delivery pen market. The report provides historical market data for 2013 - 2019, and forecasts from 2020 until 2026. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, reusable insulin pen volume, revenues for reusable...

Benzinga | October 2, 2020

Hold Novo Nordisk Stock for Consistent International Growth

The company's value chain may have been shaken by Covid-19 but it wasn't broken, so Novo Nordisk stock holders should stay invested.

InvestorPlace | September 30, 2020

Recombinant Plasma Proteins Market 2020-2025 | Growing With Major Eminent Key Players: CSL Limited, Shire, Octapharma, Novo Nordisk, Bayer, Bioverativ, Aptevo Therapeutics, Pharming, Pfizer

The exclusive research report on Global Recombinant Plasma Proteins market 2020 categorizes the market based on market overview, regions, analysis by types and applications, market dynamics, manufacturers profiles and forecast 2020-2025. Global Recombinant Plasma Proteins Market overview: The advanced exploration of alternative

OpenPR | September 28, 2020

Global Insulin Syringes Market Insights and In-Depth Analysis 2020-2027 | Abbot Laboratories, Novo Nordisk, B. Braun Melsungen AG, Medtronic PLC, etc

Insulin Syringes Market with key Business Factors and Insights The global insulin syringes market is expected to reach USD 6.89 Billion by 2027, according to a new report by Reports and Data. The growth of the market is attributed to the

OpenPR | September 28, 2020

LETTER: Local legislators vote again on insulin cap bill

To the Editor: Are you diabetic? Or do you happen to have friend or family member who has been diagnosed with diabetes? If so, you know how critical it is to have access to the wonder drug insulin. Because access to insulin can literally mean the difference between life and death, the Illinois State Legislature recently mandated a cap on the cost of insulin at $100 per 30-day supply. The Governor signed it into law and now Illinois residents are protected from price gouging on this critical medication. You would think that every single state legislator would have voted yes on this bill. And you would almost be right. It passed with strong support from both Democrats and Republicans. Our local Republican State Rep. Tom Demmer, voted no and our local Republican State Sen. Brian Stewart di...

Sauk Valley Media | September 22, 2020

Novo Nordisk insulin production line launches in Iran

Denmark’s Novo Nordisk has created an insulin production line in Iran, Mehr News Agency reported on August 31.Iran’s pharmaceutical industry …

IntelliNews | September 1, 2020

Novo Nordisk sets up insulin production line in Iran

No summary available.

UrduPoint | August 31, 2020

Insights on the Continuous Glucose Monitoring Device Global Market to 2026 - Featuring Abbott Laboratories, Medtronic & Novo Nordisk Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Continuous Glucose Monitoring Device Market By Component, By End User, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering. The Global Continuous Glucose Monitoring Device Market size is expected to reach $8.5 billion by 2026, rising at a market growth of 12.4% CAGR during the forecast period. Continuous Glucose Monitoring (CGM) is one of the newest advances in diabetes management technology. CGM

Business Wire | August 31, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5555 seconds.